Gene practices in the area of corporate and securities matters, with particular emphasis on capital markets transactions, corporate governance issuer reporting requirements and mergers and acquisitions. He has advised clients involved in public and private offerings of equity and debt, both in the United States and internationally. His work regularly includes general securities advice, tender offers and other merger and acquisition transactions, as well as alternative public offerings such as registered directs, PIPEs, at-the-market offering programs, and confidentially marketed public offerings (CMPOs). Gene is Co-Chair of the Firm's Securities and Public Companies Practice Group.
•Gene regularly advises a number of publicly traded companies in their ongoing reporting obligations, corporate governance and compliance matters, and financings.
•Gene advised Allied Healthcare International Inc. (NYSE: AHCI), a publicly traded homecare provider of health and social care in the United Kingdom and Ireland, in its $175 million acquisition by Saga Group Limited.
•Gene advised a private equity fund in its senior secured convertible note PIPE investment in a Texas-based, publicly traded healthcare company, as well as in a follow-on investment in the same company.
•Gene advised a publicly traded Massachusetts-based clean technology company in a series of CMPOs and registered direct offerings, as well as other alternative financing arrangements.
•Gene helped ABRY Partners, a private equity firm, in its $1.3 billion acquisition of RCN Corporation (NASDAQ: RCNI).
•Gene assisted Takeda Pharmaceutical Company Limited (TSE: 4502) in its $8.8 billion tender offer for Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM) in 2008, one of the largest foreign acquisitions by a Japanese company and the largest by a Japanese company in the pharmaceutical industry.
•Gene was counsel to QBE Insurance Group Limited (AUS: QBE) in its acquisition of North Pointe Holdings Corporation (NASDAQ: NPTE), a specialty commercial and personal lines insurer.
•Gene counseled an NYSE-listed telecommunications company in an issuer tender offer for certain of its employee stock options to address adverse tax consequences to optionholders arising out of an options backdating inquiry.
•Gene was counsel to GTECH Holdings Corporation in its $175 million offering of guaranteed convertible debentures to qualified institutional investors under Rule 144A, and the resale registration of the same debentures with the SEC. He was also counsel to GTECH in its offering of $250 million of senior notes, and in its September 2003 acquisition of Interlott Technologies, Inc. He later represented GTECH in its 2006 acquisition by Lottomatica S.p.A.
•He was counsel to Kingsway Financial Services, Inc., a specialty provider of personal and commercial lines of property and casualty insurance in the United States and Canada, in its unsolicited tender offer for all outstanding securities of American Country Holdings Inc.
•At his prior firm, Gene was counsel to the issuer in the $800 million global initial public offering of common shares in a leading international data network services provider. Subsequently, he served as counsel to the same issuer in the $3.1 billion follow-on public secondary offering of common shares by major shareholders. The shares were listed in New York and Paris.
•Gene was counsel to the underwriters in the $760 million global initial public offering of common shares in a leading carrier's carrier fiber-optic telecommunications company. The shares were quoted on Nasdaq and listed in London. He served as counsel to the underwriters in offering by the same issuer of high-yield senior notes. The offering consisted of a Dollar-denominated tranche and a Euro-denominated tranche, and the notes were offered in the United States under Rule 144A and overseas under Regulation S.
•Gene was counsel to the transaction in connection with the offering of $125 million in floating rate noncumulative preferred securities by a major international bank in 1999. The securities were listed in Luxembourg and qualified as Tier 1 capital for the bank.
•Gene's significant experience also includes: ongoing offerings of securities under medium term note programs; counsel to the issuer in a $700 million debt offering by a leading United Kingdom telecommunications company under its shelf registration statement; U.S. counsel to the managers in connection with a 400 million placement of exchangeable bonds by a United Kingdom electricity company; several transactions involving real estate mortgage securitization; numerous offerings under a European-based supermarket holding company's shelf program as designated underwriters' counsel; several vendor financing transactions in connection with the sale of telecommunications equipment; and several other secured lending transactions.
Before Edwards Wildman
After graduating from law school, Gene clerked for Justice Warren Matthews on the Alaska Supreme Court in Anchorage. Following the clerkship, he worked for Cleary, Gottlieb, Steen & Hamilton where he focused on international capital markets transactions in their New York and London offices. He moved to Rhode Island and joined the Firm in 2000. Gene grew up in Charleston, South Carolina.
Besides Edwards Wildman
Gene lives in Newport, Rhode Island with his wife, son and daughter. He is a member of the Board of Directors of Save The Bay (Narragansett Bay) and serves on several of its committees.
IPO of GFI Software, Provider of Network Security
A team of our London- and US-based lawyers represented venture capitalists Bessemer Venture Partners and Greenspring Associates in the public filing for a US $100 million IPO of GFI Software.
Swoop. There It is.
In 2012, an international team of our lawyers represented Massachusetts-based online advertising firm Swoop.com in the issuance of Series B Preferred Stock to US Venture Partners.
Take Private Transaction for Battery Ventures
In 2012, our private equity team completed the take-private of Jeeves Information Systems, a Swedish-headquartered, global software company which was listed on the Swedish stock exchange, on behalf of Battery Ventures, a Boston-based venture capital firm.
Battery Ventures Acquisition of Swedish Public Company
In 2012, Edwards Wildman London- and US- based Mergers & Acquisitions, PEVC, and Capital Markets lawyers represented Battery Ventures in its acquisition, by way of takeover, of Jeeves information Systems, a Swedish public company listed on NASDAQ OMX exchange.
$11 million PIPE offering by Oppenheimer & Co.
A team of Edwards Wildman lawyers represented Oppenheimer & Co. in the April 2012 $11 million PIPE offering of senior secured convertible debentures and common stock warrants.
Acquisition of Allied Healthcare by Saga Group Limited
We represented UK-based Allied Healthcare International Inc. in its acquisition for cash by merger by Saga Group Limited in October 2011.
Edwards Wildman Client Advisory: SEC Provides Helpful Guidance on Accredited Investor Verification
Edwards Wildman Client Advisory: SEC Proposes CEO Pay Ratio Disclosure Rule
September 26, 2013
Edwards Wildman Client Advisory: SEC Adopts Rules on General Solicitation That Fundamentally Change Private Capital Raising and Proposes Further Revisions
Edwards Wildman Client Advisory - SEC Approves Stock Exchanges' New Compensation Committee and Compensation Adviser Rules
Edwards Wildman Client Advisory - Stock Exchanges To Adopt New Compensation Committee and Compensation Adviser Rules
Edwards Wildman Client Advisory - Proposed SEC Rules on General Solicitation Will Fundamentally Change Private Capital Raising
Edwards Wildman Client Advisory - SEC Directs Stock Exchanges to Address Independence in Compensation Committees; Disclosure of Consultant Conflicts Also Required
Edwards Wildman Client Advisory - JOBS Act Provides New Opportunities for Private Companies
Edwards Wildman Client Advisory - The JOBS Act Changes IPO Rules for Emerging Growth Companies
Edwards Wildman Client Advisory - The JOBS Act Makes Significant Changes in the Regulation of Capital Formation and the Compliance Landscape for Many Companies
Edwards Wildman's Gene McDermott Analyzes How to Calculate Median Employee Compensation in Business Insurance
January 22, 2014
Edwards Wildman Attorneys Attends Providence Business News' Fastest Growing Companies Event
October 1, 2013
Edwards Wildman Advises Bessemer on USD35M VC Funding for NewVoiceMedia, Reports Private Equity Wire
September 24, 2013
Edwards Wildman Advises Bessemer Venture Partners on $35 Million Venture Capital Funding for NewVoiceMedia, Suppliers of Cloud Contact Centre Technology
September 19, 2013
In Law360,Gene McDermott Noted as Allied Counsel in Sale
August 1, 2011
EAPD Represents ABRY Partners in $1.2 Billion Acquisition of RCN Corporation
March 5, 2010
The Firm is Recognized in the American Lawyer
July 7, 2008
Firm Represents Takeda Pharmaceutical Company Limited in $8.8 Billion Acquisition of Millennium Pharmaceuticals
April 10, 2008
Firm Represents GTECH Holdings in Its Acquisition By Lottomatica
January 9, 2006